VivoSim推出400万美元的认股权证和两部分结构

2026-03-30 23:01

VivoSim (VIVS) plans a best-efforts public offering of up to $4M in common stock or pre-funded warrants, plus warrants tied to up to $15M in shares.
Each unit includes a share or pre-funded warrant and a warrant to buy 1.5 shares, priced at an assumed $1.69 per unit.
Common warrants are immediately exercisable, expire in five years, and include anti-dilution price protection with a $0.01 floor.
The offering includes two tranches: $3M initial and $1M second tranche subject to stock price and liquidity conditions.
Pre-funded warrants are offered to investors to avoid exceeding 4.99% or 9.99% ownership limits.
Total potential dilution includes millions of shares underlying warrants and pre-funded instruments.

More on Organovo Holdings